Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Biovector Therapeutics initiates phase II trial of melanoma vaccine

April 24, 2000

Apoptosis-initiating gene acquired by Idun

April 24, 2000

Idec enters two agreements for prostate cancer immunotherapy

April 24, 2000

BioInvent to produce therapeutic antibody for Wilex

April 20, 2000

Arisostatins identified as new tetrocarcin antibiotics with antibacterial/antitumor activity

April 20, 2000

Pharmacokinetics of SAM-486A useful in predicting toxicity

April 20, 2000

Compounds inhibiting the MDM2-p53 interaction in development by AstraZeneca

April 19, 2000

Taxol approved in Canada for adjuvant treatment of breast cancer

April 19, 2000

Genta's lead antisense drug reduces human Merkel cell tumors in mice

April 19, 2000

Matrix's IntraDose receives orphan drug status

April 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...